Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

被引：0
|
作者：
Robert S. Zhang
Allison Padegimas
Kathleen M. Murphy
Peter T. Evans
Carli J. Peters
Christopher M. Domenico
Mahesh K. Vidula
Paul J. Mather
Marisa Cevasco
Roger B. Cohen
Joseph R. Carver
Rupal P. O’Quinn
机构：
[1] University of Pennsylvania,Department of Medicine
[2] University of Pennsylvania,Division of Cardiovascular Medicine
[3] University of Pennsylvania,Division of Infectious Disease
[4] University of Pennsylvania,Department of Pharmacy
[5] University of Pennsylvania,Department of Cardiothoracic Surgery
[6] University of Pennsylvania,Division of Hematology
来源：
Cardio-Oncology | / 7卷
关键词：
Immune checkpoint inhibitor; Myocarditis; Infliximab; Cardio‐oncology; Pembrolizumab; Nivolumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Pancreatitis
    Townsend, Matthew J.
    Grover, Shilpa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S740 - S741
  • [32] Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
    Moslehi, Javid
    Salem, Joe-Elie
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 704 - 707
  • [33] A novel treatment for immune checkpoint inhibitor-related myocarditis
    Niimura, T.
    Uchida, K.
    Unten, H.
    Uno, M.
    Kanamori, M.
    Hamano, H.
    Goda, M.
    Yagi, K.
    Aizawa, F.
    Izawa-Ishizawa, Y.
    Zamami, Y.
    Ishizawa, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1634 - S1634
  • [34] Immune Checkpoint Inhibitor Myocarditis: Current Views on Diagnosis and Treatment
    Chocholova, Barbora
    Kuchynka, Petr
    Palecek, Tomas
    COR ET VASA, 2022, 64 (03) : 310 - 315
  • [35] Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review
    Lai, Kuan-Chang
    Hsiao, Yi-Han
    Chen, San-Chi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Steroids in Immune Checkpoint Inhibitor Myocarditis
    Palaskas, Nicolas L.
    Siddiqui, Bilal A.
    Deswal, Anita
    JACC: CARDIOONCOLOGY, 2024, 6 (05): : 800 - 803
  • [37] IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS
    Abdolall, Ali K.
    Srivastava, Geetika
    Abdelnour, John
    Balakumaran, Kathir
    Aneja, Ashish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3482 - 3482
  • [38] Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
    Corrigan, Margaret
    Haydon, Geoffrey
    Thompson, Fiona
    Rajoriya, Neil
    Peplow, Claire L.
    Hubscher, Stefan G.
    Steven, Neil
    Hirschfield, Gideon M.
    Armstrong, Matthew J.
    JHEP REPORTS, 2019, 1 (01) : 66 - 69
  • [39] Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis
    McNally, Bridgette B.
    Sivakumar, Angiela
    Haddad, Nael
    Suchartlikitwong, Sakolwan
    Aguon, Paul Muna
    Fung, Brian M.
    Zucker, Kelly
    David, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S756 - S756
  • [40] Use of a JAK inhibitor for the treatment of steroid- and infliximab-refractory colitis under immune checkpoint inhibitor therapy with ipilimumab/nivolumab - a case report
    Reiser, S.
    Naoum, C.
    Gauss, A.
    Enk, A.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 53 - 53
12345